The question of why clubfoot is more common in developing countries is complex and multi-layered. While the birth prevalence of clubfoot is roughly similar worldwide — approximately 1-2 per 1,000 live births — reported rates in low- and middle-income countries (LMICs) appear higher. This disparity reflects a combination of genuine risk factors, reporting differences, and the staggering burden of untreated cases that accumulate when treatment services are unavailable. This article unpacks the evidence behind global clubfoot disparities.
Global Prevalence: What the Data Actually Shows
Clubfoot occurs in every population on earth. However, reported prevalence varies significantly:
- Europe and North America: 1.0-1.5 per 1,000 live births
- Sub-Saharan Africa: 1.5-3.0 per 1,000 live births (some regions higher)
- South and Southeast Asia: 1.5-2.5 per 1,000 live births
- Pacific Islands (Polynesia, Maori populations): Up to 6-7 per 1,000 live births
- China and Japan: 0.5-1.0 per 1,000 live births
In the UK, the NHS records approximately 1 in 1,000 births affected by clubfoot, with treatment delivered through a well-established NHS pathway. The UK is one of the countries where the Ponseti method is universally available, meaning virtually all cases are identified and treated promptly.
Genuine Risk Factors More Prevalent in LMICs
Nutritional Deficiencies
Research has identified several nutritional factors associated with increased clubfoot risk, and these deficiencies are more common in developing countries:
- Folic acid: Insufficient maternal folic acid intake during early pregnancy has been linked to higher rates of clubfoot in several studies. In high-income countries, folic acid supplementation before and during pregnancy is standard practice. In many LMICs, neither supplementation nor food fortification is widely available.
- General malnutrition: Maternal undernutrition during pregnancy is associated with a range of congenital anomalies, including musculoskeletal conditions. Severe caloric restriction and protein deficiency may affect fetal limb development.
- Vitamin D deficiency: Some studies suggest a correlation between low maternal vitamin D levels and clubfoot risk, though the evidence is less conclusive than for folic acid.
Maternal Smoking and Substance Exposure
Maternal smoking during pregnancy is a well-established risk factor for clubfoot, with studies showing a dose-response relationship — more cigarettes per day correlates with higher risk. While smoking rates have declined in many high-income countries, they remain high in parts of Eastern Europe, South America, and Asia. Additionally, exposure to biomass smoke from cooking fires (common in rural areas of LMICs) has been proposed as a potential risk factor, though this requires further study.
For a comprehensive review of risk factors, see our article on what causes clubfoot.
Genetic Factors and Consanguinity
Clubfoot has a strong genetic component. In populations where consanguineous (related) marriages are more common — such as parts of the Middle East, North Africa, and South Asia — the rate of autosomal recessive conditions, including some forms of clubfoot, tends to be higher. When both parents carry a recessive gene variant associated with clubfoot, their offspring have a 25% chance of being affected.
Certain ethnic populations also have genuinely higher baseline rates of clubfoot that appear to be genetic in origin. Polynesian and Maori populations have rates of 6-7 per 1,000, which persist even among these populations living in high-income countries like New Zealand, suggesting a genetic rather than environmental cause.
Environmental Exposures
Exposure to environmental toxins during pregnancy — including pesticides, industrial chemicals, and contaminated water sources — has been associated with various congenital anomalies. Agricultural workers in LMICs often have higher exposure to organophosphate pesticides, which have been implicated in musculoskeletal birth defects in animal studies. The evidence in humans is limited but suggestive.
Reporting and Surveillance Differences
Not all of the apparent disparity in clubfoot rates reflects genuine differences in incidence. Several reporting factors contribute:
Birth Registration and Screening
In countries with universal newborn screening (such as the UK), virtually every case of clubfoot is identified at birth or prenatally via ultrasound. In many LMICs, a significant proportion of births occur at home without trained healthcare workers present. Mild cases may go unrecognised or unreported, while severe cases accumulate untreated in the community, creating the impression of higher prevalence when population surveys are conducted.
Prevalence vs Incidence
A crucial distinction often overlooked in media reports is the difference between incidence (new cases per year) and prevalence (total existing cases). In the UK, most children with clubfoot complete treatment by age 5, meaning the prevalence of active clubfoot in the community is low. In countries without treatment services, every child born with clubfoot adds to the cumulative prevalence indefinitely. A country might have a similar birth rate of clubfoot to the UK but a vastly higher prevalence because cases persist untreated for decades.
Higher Birth Rates
Countries with higher overall birth rates will, in absolute numbers, have more cases of clubfoot — even if the rate per 1,000 births is similar. Sub-Saharan Africa, for instance, has both the world's highest birth rates and the greatest absolute number of untreated clubfoot cases.
Access to Treatment: The Real Crisis
The disparity that matters most is not in clubfoot occurrence but in treatment access. In the UK, a child born with clubfoot today will receive Ponseti treatment within weeks and can expect a functionally normal outcome. In many developing countries, the same child faces a lifetime of disability.
Barriers to Treatment in LMICs
- Shortage of trained practitioners: The Ponseti method requires specific training, and many LMICs have too few trained orthopaedic specialists. Some countries have fewer than one orthopaedic surgeon per million people.
- Geographic access: Treatment centres are concentrated in urban areas. Families in rural regions may live days of travel from the nearest clinic capable of Ponseti casting.
- Cost: Even where treatment is available, the cost of repeated clinic visits, casts, and braces can be prohibitive. In the UK, all clubfoot treatment is free through the NHS. In many LMICs, families must pay out of pocket.
- Brace availability: The boots and bar used in the maintenance phase of Ponseti treatment are expensive and not always available locally. International organisations have developed lower-cost alternatives, but supply chain issues persist.
- Cultural beliefs: In some communities, clubfoot is attributed to supernatural causes or seen as a curse. This can delay or prevent families from seeking medical treatment.
- Follow-up challenges: The Ponseti method requires weekly clinic visits during casting and years of brace use. For families without reliable transport or who cannot take time off work, maintaining this schedule is extremely difficult.
Organisations Working to Close the Gap
Several international organisations are working to expand Ponseti treatment in LMICs:
- MiracleFeet: Partners with local organisations in over 30 countries to establish sustainable clubfoot treatment clinics
- Global Clubfoot Initiative (GCI): Coordinates training and capacity building for Ponseti practitioners worldwide
- CURE Clubfoot: Operates treatment programmes across Africa and Asia
- Uganda Sustainable Clubfoot Care Project: A model programme that has been replicated in other East African countries
These efforts have made remarkable progress. In Uganda, for example, the national Ponseti programme now reaches over 80% of new clubfoot births, compared to less than 10% two decades ago.
What the UK Can Learn
While the UK's clubfoot treatment system is among the best in the world, there are lessons to draw from the global experience:
- The importance of maintaining brace compliance — relapse rates are a challenge in every country, including the UK
- The value of community-based support — programmes that train parents and community health workers to monitor treatment achieve better outcomes
- The need for long-term follow-up — even well-treated clubfoot requires monitoring into adolescence, and NHS resources for this are sometimes stretched
Frequently Asked Questions
Q: Is clubfoot caused by poverty?
A: No. Clubfoot is primarily a congenital condition with genetic and environmental contributions. It occurs across all socioeconomic groups. However, certain risk factors (nutritional deficiencies, smoking, environmental exposures) are more common in lower-income populations, which may contribute to slightly higher rates. The main impact of poverty is on access to treatment, not on the occurrence of the condition itself.
Q: Could better nutrition during pregnancy prevent clubfoot?
A: Adequate folic acid intake before and during early pregnancy is associated with lower rates of several congenital anomalies, including clubfoot. The NHS recommends 400 micrograms of folic acid daily from before conception until 12 weeks of pregnancy. However, clubfoot has multiple causes, and nutrition is only one contributing factor — not all cases can be prevented through diet alone.
Q: Why do some ethnic groups have higher rates of clubfoot?
A: The variation appears to be largely genetic. Polynesian and Maori populations have clubfoot rates of 6-7 per 1,000 — approximately six times the European average — and this persists across different environments and socioeconomic conditions. Specific gene variants associated with limb development are more common in these populations. Conversely, East Asian populations tend to have lower rates. These differences likely reflect normal human genetic diversity rather than any preventable cause.
Q: Is the Ponseti method available in developing countries?
A: Increasingly, yes. Over the past two decades, major international efforts have expanded Ponseti training and services across Africa, Asia, and South America. The Ponseti method is particularly well-suited to resource-limited settings because it requires minimal equipment — just plaster bandages, a trained practitioner, and a brace. However, coverage remains incomplete, and millions of children still lack access to treatment. Charitable organisations continue to work toward universal availability.
Further support: Clubfoot Treatment in Developing Countries: Progress.